Patients with the syndrome of resistance to thyroid hormone (RTH) exhibit inappropriate section of TSH and elevated thyroid hormone levels due to mutations occurring in the beta gene of the thyroid hormone receptor (TR). The TR-beta gene encodes two isoforms and it is unclear whether both isoforms are equally important in negative regulation of TSH secretion by T/3 or how mutant TR-beta isoforms function to cause RTH. In vitro studies suggest that the TR-beta isoforms differ in their ability to mediate negative regulation of TRH and TSH subunit gene transcription by T/3 and vary in their function as dominant negative inhibitors of gene expression in RTH. Physiological studies in vivo are lacking, however, to confirm the significance of these findings. This proposal will test whether differences in TR-beta isoform regulation of TSH subunit gene expression by T/3 are relevant in vivo and are responsible for distinct syndromes of resistance to thyroid hormone (RTH).
Three specific aims are proposed to elucidate the function of TR- beta isoforms in normal and T/3 resistance states. In the first aim, the specific role of the TR-beta2 isoform in the regulation of TRH and TSH subunit gene expression in vivo will be determined through targeted disruption of the TR-beta2 isoform in mice. In the second aim, the function of nuclear hormone receptor co-repressor protein (NCoR) on pituitary thyroid function will be determined in vivo by targeted over- expression of an NCoR inhibitor in transgenic mice. Finally, in third aim, the relative roles of the TR-beta isoforms in mediating distinct syndromes of resistance to thyroid hormone (RTH) will be assessed by expression of mutant TRs, in the context of either a TR-beta1 or TR- beta2 isoform, in the hypothalamus or pituitary or transgenic animals. The overall goal of this proposal is to clarify the function of TR-beta isoforms in vivo by utilizing physiologically relevant model systems. Determination of TR isoform-specific regulation of gene expression in vivo would yield novel insights into thyroid hormone action in man.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK053036-05
Application #
6628539
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
1999-02-15
Project End
2005-01-31
Budget Start
2003-02-01
Budget End
2005-01-31
Support Year
5
Fiscal Year
2003
Total Cost
$246,852
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Richter, Claus-Peter; Munscher, Adrian; Machado, Danielle Santana et al. (2011) Complete activation of thyroid hormone receptor ýý by T3 is essential for normal cochlear function and morphology in mice. Cell Physiol Biochem 28:997-1008
Machado, Danielle S; Sabet, Amin; Santiago, Leticia A et al. (2009) A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad Sci U S A 106:9441-6
Alonso, Manuela; Goodwin, Charles; Liao, Xiaohui et al. (2009) In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice. Endocrinology 150:3927-34
Nikrodhanond, Amisra A; Ortiga-Carvalho, Tania M; Shibusawa, Nobuyuki et al. (2006) Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem 281:5000-7
Hashimoto, Koshi; Cohen, Ronald N; Yamada, Masanobu et al. (2006) Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem 281:295-302
Ortiga-Carvalho, Tania M; Shibusawa, Nobuyuki; Nikrodhanond, Amisra et al. (2005) Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J Clin Invest 115:2517-23
Ortiga-Carvalho, Tania M; Hashimoto, Koshi; Pazos-Moura, Carmen C et al. (2004) Thyroid hormone resistance in the heart: role of the thyroid hormone receptor beta isoform. Endocrinology 145:1625-33
Cohen, R N; Brzostek, S; Kim, B et al. (2001) The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol 15:1049-61
Pachucki, J; Hopkins, J; Peeters, R et al. (2001) Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology 142:13-20
Hashimoto, K; Curty, F H; Borges, P P et al. (2001) An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci U S A 98:3998-4003

Showing the most recent 10 out of 11 publications